Also, gold nanoparticles targeted the epigenetic pathway for acute myeloid leukemia therapy, by targeting the NCL/miR-221/NFkB/DNMT1 signaling pathway [107]. This evidence concerns the gene DNMT1 and acute myeloid leukemia.